Idaho to Receive Another $76 Million in Opioid Settlement From Pharmacies, Drug Manufacturers

Idaho Attorney General Raúl Labrador announced another opioid settlement agreement this week that will help the state combat the opioid crisis. Over the next 15 years, Idaho will receive $76 million from chain pharmacies CVS and Walgreens and drug manufacturers Teva and Allergan.

Under the $17.3 billion multistate agreement, Allergan is required to stop selling opioids for the next 10 years and Teva is required to stop opioid marketing and ensure systems are in place to prevent drug misuse. CVS and Walgreens have agreed to monitor, report, and share data about suspicious activity related to opioid prescriptions.

This settlement is one of many over the last few years between states and the pharmaceutical industry for its role in the opioid crisis.

Read the source article at idahocountyfreepress.com